Quintiles Press Releases Feed

Quintiles’ New Health Report Evaluates the Risk Equation in Biopharmaceutical Medicine

Tue, 22 May 2012 08:15:00 -0400

May 22, 2012 – The constellation of stakeholders in the healthcare industry most responsible for the progress of medicine do not agree on a common lens from which to view risk for their own purposes, nor for the other stakeholders they are dependent upon.

Quintiles Names Tom Pike CEO

Mon, 23 Apr 2012 06:00:00 -0400

April 23, 2012 – Quintiles, the world’s leading global biopharmaceutical services company announced the appointment of Tom Pike as chief executive officer. Dennis Gillings, CBE, who founded the company, continues as executive chairman of its Board of Directors. Pike joins Quintiles on April 30, 2012.

Quintiles Grants $10,000 in Scholarships to City of Medicine Academy Graduates

Fri, 20 Apr 2012 08:00:00 -0400

April 20, 2012 – Quintiles will grant four scholarships to 2012 graduates from the City of Medicine Academy in Durham, North Carolina as the biopharmaceutical services company celebrates its 30-year anniversary.

Quintiles’ Digital Media Innovation Receives Further Recognition

Wed, 18 Apr 2012 08:15:00 -0400

April 18, 2012 – Quintiles’ ground-breaking embrace of digital media to improve many aspects of its work has received further acclaim, this time for helping employees connect and work together more effectively.

Quintiles Wins Best CRO In Vaccine Excellence Awards 2012

Thu, 12 Apr 2012 13:30:00 -0400

April 12, 2012 – Quintiles, the world’s leading global biopharmaceutical services company, announced that it has been named Best Clinical Research Organization (CRO) in the Vaccine Industry Excellence (ViE) Awards 2012.

American Diabetes Association to Collaborate with Quintiles’ Digital Patient Unit

Wed, 04 Apr 2012 08:30:00 -0400

April 4, 2012 – Quintiles and the American Diabetes Association announced a strategic agreement in which Quintiles’ Digital Patient Unit will provide the Association’s millions of website users access to Quintiles’ medication monitoring service.

Quintiles to Quantify Healthcare Decisions

Wed, 28 Mar 2012 09:34:49 -0400

Quintiles incorporates Archimedes’ ARCHeS Innovator into its existing solutions that span the product lifecycle.

Quintiles Highlights Potential of Asia to Transform BioPharma

Wed, 14 Mar 2012 20:30:00 -0400

March 14, 2012 – With the biopharmaceutical industry currently balanced atop tectonic plates, industry leaders must not settle on incremental innovation, but should look toward Asia as a unique opportunity for “radical transformation,” according to a paper from Quintiles.

Quintiles Celebrates 30 Years as Biopharma Services Provider

Tue, 28 Feb 2012 06:00:00 -0400

February 28, 2012 - Quintiles marks the 30-year anniversary of the company’s incorporation, transforming from a small statistical consulting firm to the world’s largest biopharmaceutical services company.

Quintiles and Russian Venture Company Biofund to Expand Clinical Development Capabilities in Russia

Fri, 24 Feb 2012 02:00:00 -0400

February 24, 2012 – Russian Venture Company Biofund, and Quintiles, announced a definitive agreement to support expansion of clinical development services within the Russian Federation, the world’s ninth most populous country.

Quintiles Expands Commercial Services in Middle East and North Africa

Tue, 14 Feb 2012 18:00:00 -0400

February 14, 2012 – Quintiles is extending its global footprint to provide commercial services in the Middle East and North Africa (MENA) region through an agreement with Dayarn Pharma.

Quintiles Launches New Capabilities to Enable Biopharma Success in Asia

Thu, 09 Feb 2012 05:37:06 -0400

February 13, 2012 – Quintiles launches two unique services – Strategic Drug Development and Consulting at Quintiles – to bolster the probability of success in developing and commercializing new medications in the region.

Quintiles Forms New Biomarker Research and Development Company

Wed, 18 Jan 2012 06:00:00 -0400

January 18, 2012 – Quintiles announced that it has invested in a new company formed to provide oncology consulting services and new cancer biomarkers, the key to scientific selection of the right drug for the right patient.

Quintiles Launches Innovative Center of Excellence in Dalian, China

Tue, 17 Jan 2012 13:22:07 -0400

January 17, 2012 – Quintiles is opening a business process outsourcing (BPO) and project management center of excellence with a multilingual workforce and location ideally suited to serve the Japanese, Chinese and South Korean biopharmaceutical markets.

Mediguard's 2.5 Million-Strong Patient Community Offers Safe Home for Former Google Health Users

Wed, 04 Jan 2012 09:49:14 -0400

January 4, 2012 - With the ringing in of the new year, patients and family members of the now bygone Google Health can still find a well established, thriving and successful online option for managing personal healthcare information in Quintiles’ MediGuard.org service.

Quintiles Forms Digital Patient Unit

Tue, 03 Jan 2012 11:54:41 -0400

January 3, 2012 - Quintiles today announced the formation of its new Digital Patient unit which brings together the company’s online communities and digital expertise to directly engage with patients.

Intarcia and Quintiles Finalize Innovative Alliance

Tue, 13 Dec 2011 07:43:17 -0400

December 13, 2011 – To speed development of a potential ground-breaking therapy for Type 2 diabetes – Intarcia Therapeutics, Inc., and Quintiles announced the signing of definitive agreements making Quintiles a financial and strategic partner for the global clinical development of Intarcia’s ITCA 650 (DUROS® continuous subcutaneous delivery of exenatide).

Quintiles Launches China CRO, Kun Tuo

Tue, 13 Dec 2011 07:01:52 -0400

December 13, 2011 – Further deepening its commitment to China, Quintiles announced the launch of Kun Tuo, a local contract research organization (CRO) built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China.

Quintiles Expands World's Largest Cap-Accredited Lab Network

Thu, 01 Dec 2011 08:00:00 -0400

December 1, 2011 – Continuing the expansion of its Global Laboratories’ capabilities and resources, Quintiles announced the opening of a new, expanded central lab in Centurion, South Africa.

Quintiles and Prodia Partner to Provide Central Lab Testing Solution in Indonesia

Wed, 30 Nov 2011 02:00:00 -0400

November 30, 2011 – Quintiles announced an expanded partnership with Jakarta-based Prodia Clinical Laboratory, through its sister company Prodia the CRO, to facilitate rapid testing of samples from patients in clinical trials in Indonesia.

Quintiles Named 2011 Frost & Sullivan Asia Pacific CRO of the Year

Tue, 29 Nov 2011 16:40:33 -0400

November 29, 2011 – For the fourth time in six years, Quintiles has been named Asia Pacific Contract Research Organization of the Year by Frost & Sullivan.

Quintiles Sells Minority Interest in Invida

Tue, 15 Nov 2011 16:31:22 -0400

November 15, 2011 – Quintiles has sold its minority interest in Invida, an Asia Pacific commercial solutions joint venture, to the Italy-based Menarini Group, which is acquiring Invida in its entirety.

Quintiles Completes Acquisition of Advion BioServices

Mon, 07 Nov 2011 06:00:00 -0400

November 7, 2011 – Quintiles’ ability to provide customers with actionable early-stage data to make better development decisions faster has taken a significant step forward with the closing of the previously announced agreement to acquire Advion BioServices, a premier U.S.-based bioanalytical laboratory.

Quintiles Receives Accolades for Connecting Patients to Clinical Research

Thu, 03 Nov 2011 09:54:43 -0400

November 3, 2011 – Quintiles’ digital efforts to bridge the gaps between clinical research, patients and clinical trial participants have been recognized in the form of two International Davey Awards and a Web Health Award this week.

Quintiles Recognized as a Top Multinational Employer

Fri, 28 Oct 2011 08:47:39 -0400

October 28, 2011 – Quintiles is ranked 25th in the inaugural World’s Best Multinational Workplaces list from the Great Place to Work® Institute.

Quintiles Agrees to Acquire Premier GLP Bioanalytics Laboratory

Wed, 26 Oct 2011 09:03:53 -0400

October 26, 2011 – To provide a more comprehensive and efficient global solution for its laboratory customers, Quintiles signed of a definitive agreement to acquire Advion BioServices.

Quintiles Strengthens Late Phase Offerings with Acquisition of Outcome Sciences, Inc.

Wed, 19 Oct 2011 12:30:00 -0400

October 19, 2011 – With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, Inc. (Outcome).

Quintiles Acquires VCG & Associates and VCG Bio

Wed, 19 Oct 2011 08:30:00 -0400

October 19, 2011 – The acquisition of VCG & Associates and VCG BIO strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.

Quintiles Consolidates EU Business with Headquarters in UK

Wed, 12 Oct 2011 00:00:00 -0400

October 12, 2011 – Quintiles, the only fully integrated bio pharmaceutical services provider offering clinical, commercial, consulting and capital solutions worldwide, officially opened its new European Headquarters in Reading, United Kingdom, bringing together employees from each of its four disciplines.

Quintiles Names New Global Head of Clinical & Data Operations

Thu, 06 Oct 2011 06:00:00 -0400

October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.

Quintiles Addresses Key Considerations for Successful Biosimilar Development

Fri, 30 Sep 2011 14:53:19 -0400

September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.

Partnering is Key to Maximizing Rewards in Emerging Markets

Tue, 27 Sep 2011 06:00:00 -0400

September 27, 2011 – While biopharmaceutical spending in emerging markets is growing at double-digit rates – much faster than in developed nations – opportunities in “pharmerging” countries must be balanced with accompanying costs and risks of entering new markets.

Quintiles Names Charles Williams to Serve as Worldwide Controller

Thu, 22 Sep 2011 07:57:46 -0400

September 22, 2011 - Quintiles has named Charles Williams to serve as its worldwide controller within the company’s finance organization. A 34-year veteran of corporate finance and accounting, Williams reports directly to Chief Financial Officer Kevin Gordon.

Quintiles Approach to "Real-World" Research helps Biopharma Customers Drive Competitive Advantage

Mon, 19 Sep 2011 06:00:00 -0400

September 19, 2011 –A perfect storm of stakeholder demands, unprecedented data access, new data channels and technologies is driving a dramatic shift in research methodologies among biopharmaceutical companies, according to a new report from Quintiles.

Quintiles Market Research Expert Honored by American Marketing Association Foundation

Thu, 15 Sep 2011 10:37:48 -0400

September 15, 2011 – Quintiles announced that The American Marketing Association (AMA) Foundation selected an article co-authored by Pieter Sheth-Voss, of Consulting at Quintiles, to receive the 2011 David K. Hardin Award.

Quintiles Recognized as One of The Best Technology Innovators & Industry Leaders by InformationWeek

Wed, 14 Sep 2011 08:50:37 -0400

September 14, 2011 – Quintiles was named 4th in the prestigious InformationWeek 500 technology innovators rankings for its Quintiles INFOSARIO™ platform. The company was also recognized as the industry leader in the biotech and pharmaceutical category.

Quintiles Appoints Global Head of Phase I Division

Wed, 31 Aug 2011 09:00:00 -0400

August 31, 2011 – Quintiles announced that Oren Cohen, M.D., will serve as Senior Vice President and Global Head of its Phase I Clinical Research division, which includes world-class facilities in Overland Park, Kansas (U.S.), London (U.K.) and Hyderabad (India).

Quintiles President of Clinical Development Receives 'Women in Business' Award

Fri, 26 Aug 2011 14:00:00 -0400

August 26, 2011 – Quintiles announced that Paula Brown Stafford, President of Clinical Development, was honored as a recipient of Triangle Business Journal’s Women in Business awards for 2011.

Quintiles Names Jeffrey Spaeder Chief Medical and Scientific Officer

Wed, 03 Aug 2011 15:08:53 -0400

August 3, 2011 - Quintiles announced the appointment of Jeffrey A. Spaeder, M.D., as its Chief Medical and Scientific Officer, representing the company's position on a wide variety of governance, ethical and scientific issues.

Quintiles, Kadrige Open E-Solutions Operation in the US

Tue, 02 Aug 2011 09:07:36 -0400

August 2, 2011 – Quintiles and Kadrige, the market leader in e-detailing and multichannel sales solutions for the pharmaceutical and healthcare industries, today announced the opening of the first Kadrige office in the U.S.

Economist Intelligence Unit, Quintiles Find Innovation is Vital to Future of Biopharma

Tue, 12 Jul 2011 06:00:00 -0400

July 12, 2011 – A new Economist Intelligence Unit survey sponsored by Quintiles highlights the urgent need for bio pharmaceutical industry innovation.

Quintiles, Queen Mary University Collaborate to Accelerate Clinical Research

Thu, 07 Jul 2011 00:00:00 -0400

July 7, 2011 – Quintiles reached a significant milestone in its prime site program with the official opening of a clinical research facility within Queen Mary, University of London.

Quintiles Helps Biopharma Companies Turn Compliance into a Business Advantage

Wed, 29 Jun 2011 09:30:00 -0400

June 29, 2011 – Elevating compliance to achieve a strategic advantage allows biopharmaceutical companies to respond more rapidly to ever-changing conditions in the New Health, according to a new report from Consulting at Quintiles.

Quintiles Wins Best CRO in Vaccine Excellence Asia Awards 2011

Thu, 23 Jun 2011 12:04:45 -0400

June 23, 2011 – Quintiles, a leading global biopharmaceutical services company, today announced that it has been named Best Clinical Research Organization (CRO) in the Vaccine Industry Excellence (ViE) Asia Awards 2011.

Quintiles Honored by Computerworld as One of the Best Places to Work in IT

Wed, 22 Jun 2011 11:09:52 -0400

June 22, 2011 - Quintiles has been named to Computerworld magazine’s “100 Best Places to Work in IT” list for a third time.

Quintiles Infosario™ Integrates Data to Eliminate Silos within Drug Development Continuum

Mon, 20 Jun 2011 12:00:00 -0400

June 20, 2011 – Quintiles announced the release of Quintiles Infosario, a business-to-business platform that enables customers to leverage data for improved collaboration and decision-making throughout the drug development process.

Quintiles Appoints New Head of Late Phase Operations

Thu, 09 Jun 2011 09:19:39 -0400

June 9, 2011 – Quintiles announced the appointment of Dr. Cynthia L. Verst as Global Head of Late Phase Operations.

Quintiles Completes Refinancing

Wed, 08 Jun 2011 10:32:48 -0400

June 8, 2011 – Quintiles Transnational Corp. (the “Company”), today announced that it has completed new $2.2 billion credit facility arrangements.

Quintiles Named a Top 25 Workplace Across Europe

Thu, 02 Jun 2011 07:00:00 -0400

June 1, 2011 - Quintiles, the only fully integrated bio pharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, has qualified as one of the 25 best workplaces in Europe.

KoNECT & Quintiles Partner to Advance Clinical Research

Mon, 30 May 2011 01:00:00 -0400

May 30, 2011 – The Korea National Enterprise for Clinical Trials (KoNECT) and Quintiles have partnered to produce educational events in South Korea for investigators and biopharmaceutical companies.

Quintiles' New Health Report 2011 Shows Optimistic Future for Drug Development

Tue, 24 May 2011 00:00:00 -0400

May 24, 2011 – Primary stakeholders foresee better prescription medicines in the U.S. over the next decade. However, they disagree on a number of vital healthcare issues.

Quintiles Transnational Holdings Announces Extension of Consent Deadline

Mon, 23 May 2011 21:10:10 -0400

May 23, 2011 – Quintiles Transnational Holdings Inc. (the “Company”), parent of Quintiles Transnational Corp. (“Quintiles”), announced that it has extended the consent payment deadline for its previously announced tender offer.

Quintiles Names Rick Sax New Head of Integrated Clinical Services

Mon, 23 May 2011 09:30:00 -0400

May 23, 2011 – Quintiles announced the appointment of Frederic “Rick” Sax as Senior Vice President and Global Head of its Integrated Clinical Services division.rograms.

Quintiles and Population Genetics Technologies Partner

Mon, 16 May 2011 00:00:00 -0400

May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.

Quintiles Recommences Refinancing Process, Quintiles Holdings Announces Debt Tender Offer

Tue, 10 May 2011 17:19:38 -0400

May 10, 2011– Quintiles Transnational Corp. (the “Company”) announced that it is pursuing plans to enter into new $2.2 billion credit facilities.

Quintiles to Support Innovative I-Spy 2 Breast Cancer Clinical Trial

Thu, 14 Apr 2011 08:00:00 -0400

April 14, 2011 - Quintiles will contribute $2.6 million over four years to support I-SPY 2, a unique adaptive clinical trial designed to develop breast cancer therapies twice as quickly and at one-fifth the cost of current methods.

Quintiles Reaches New Milestone in Social Health

Mon, 28 Mar 2011 14:07:47 -0400

March 28, 2011 – Quintiles announced that its online social community at www.MediGuard.org has reached 2.5 million members in just three years.

Quintiles Named a Preferred Provider to Global Health Product Development Partnership Consortium

Fri, 25 Mar 2011 07:18:56 -0400

March 25, 2011 – Quintiles has been named a preferred provider to a consortium of 14 global health Product Development Partnerships (PDPs).

Quintiles Postpones Proposed Financing and Terminates Tender Offer

Tue, 22 Mar 2011 16:02:30 -0400

March 22, 2011 - As a result of recent unfavorable global credit market conditions, Quintiles Transnational Corp. (“Quintiles”) it has postponed its previously announced plans to enter into new $2.425 billion credit facilities.

Asia is Key to Driving Innovation in Drug Development and Overcoming Industry Challenges

Sun, 13 Mar 2011 00:00:00 -0400

March 13, 2011 – Asia is rapidly becoming a new frontier for drug development as Western companies seek to develop and register their products, while emerging Asian companies seek new capabilities to globalize products.

Quintiles Transnational Holdings Commences Tender Offer

Thu, 10 Mar 2011 17:00:00 -0400

March 10, 2011 - Quintiles Transnational Holdings Inc. announced that it has commenced a cash tender offer for any and all of the Company’s outstanding $525.0 million aggregate principal amount 9.50% senior notes due 2014.

Quintiles Commences Refinancing Process

Tue, 08 Mar 2011 08:00:00 -0400

March 8, 2011 – Quintiles is pursuing plans to enter into new $2.425 billion credit facilities.

Quintiles Supports Samsung's Entry into BioPharma Market through Joint Venture

Mon, 28 Feb 2011 00:00:00 -0400

February 28, 2011 – The Samsung Group, South Korea’s largest industrial group, has entered into a strategic partnership with Quintiles, to support Samsung’s entry into the bio pharmaceuticals market.

Quintiles Central Laboratory Awarded Accreditation to the International Standard for Quality Management

Wed, 23 Feb 2011 09:50:01 -0400

February 23, 2011 – Quintiles lab is one of only of a limited number of central labs in the U.S. to meet the rigorous requirements for medical laboratory quality and competence established by the International Organization for Standardization (ISO).

Quintiles Again Named to Training "Top 125"

Fri, 11 Feb 2011 06:00:00 -0400

February 11, 2011 - For the third year in a row, Quintiles has been recognized as one of the top organizations in the world for workforce training and development excellence with its inclusion in the Training “Top 125.”

Quintiles Websites Empower Patients

Tue, 01 Feb 2011 16:47:37 -0400

February 1, 2011 – Quintiles’ ClinicalResearch.com and MediGuard.org websites have been honored by the prestigious Web Health Awards for empowering patients to make better informed health decisions.

Quintiles Speeds Early-Phase Decision Making with New Unit in Hyderabad, India

Mon, 24 Jan 2011 08:52:51 -0400

January 24, 2011 – Quintiles officially opened its new Phase I research facility in Hyderabad, India at Apollo Health City.

QUINTILES APPOINTS VINCENT AURENTZ TO LEAD CUSTOMER SOLUTIONS BUSINESS

Thu, 16 Dec 2010 09:00:00 -0400

December 16, 2010 - – Quintiles announced the appointment of Vincent Aurentz as Executive Vice President, Customer Solutions Business, to head a newly formed unit of dedicated customer teams that will deliver customized solutions across Quintiles’ global businesses.

QUINTILES, LONDON GENETICS ALLY TO ENHANCE DRUG DISCOVERY AND DEVELOPMENT THROUGH PHARMACOGENETICS

Mon, 29 Nov 2010 09:00:00 -0400

November 29, 2010 – Quintiles, London Genetics alliance combines world-class expertise, global infrastructure to support biopharma in developing personalized medicine.

QUINTILES AND KADRIGE PARTNER TO IMPROVE COMMERCIALIZATION OF PHARMACEUTICAL BRANDS

Tue, 16 Nov 2010 09:00:00 -0400

November 16, 2010 – Quintiles, and Kadrige, announce a global alliance that brings innovative models to physician detailing to help biotech and pharmaceutical companies increase productivity, overcome complexity and more efficiently demonstrate value for their therapies.

BIOMODA SELECTS QUINTILES TO HELP DEVELOP MORE ACCURATE AUTOMATED SYSTEM FOR DETECTING EARLY-STAGE LUNG CANCER

Mon, 15 Nov 2010 09:00:00 -0400

November 15, 2010 – Cancer diagnostics company Biomoda, Inc. has allied with Quintiles' Central Laboratories to help refine the automated image recognition system for measuring the photon emission rate and cell morphology of CyPath®-stained cells to detect early stage lung cancer.

QUINTILES WINS SCRIP AWARDS ‘BEST CLINICAL RESEARCH ORGANIZATION’ FOR SECOND CONSECUTIVE YEAR

Wed, 10 Nov 2010 14:25:12 -0400

November 9, 2010 - For the second consecutive year, Quintiles has received Scrip Awards Best Clinical Research Organization honors based upon judging by an independent panel of prestigious life sciences experts.

DAKO AND QUINTILES FORM ALLIANCE TO SPEED DEVELOPMENT OF PERSONALIZED MEDICINE

Mon, 01 Nov 2010 09:00:00 -0400

November 1, 2010 - Dako and Quintiles announced a strategic alliance to advance personalized medicine by collaborating on the co-development of targeted therapies and companion diagnostics.

QUINTILES UNVEILS GLOBAL SERVICE OPERATIONS CENTER

Thu, 21 Oct 2010 17:27:25 -0400

October 22, 2010 - Quintiles announced the official opening of its new Global Information Technology (IT) Service Operations Center in Bangalore, India providing intelligent monitoring, control and triage of system events across Quintiles’ technology cloud.

EXAMINING REAL-TIME DATA TO IMPROVE THE QUALITY AND EFFICIENCY OF DRUG DEVELOPMENT

Wed, 13 Oct 2010 06:00:00 -0400

October 13, 2010 – White Paper authors explore how real-time data can enhance patient safety, strengthen quality and accelerate development timelines.

QUINTILES TO BE KEY PARTICIPANT AT SOCIETY FOR CLINICAL DATA MANAGEMENT ANNUAL CONFERENCE

Tue, 12 Oct 2010 08:42:03 -0400

October 12, 2010 - Quintiles’ Paula Brown Stafford, President, Clinical Development will open the conference with a keynote speech on the evolution from data management to information management.

QUINTILES PARTNERS WITH THE SEOUL NATIONAL UNIVERSITY HOSPITAL

Wed, 06 Oct 2010 12:00:00 -0400

October 6, 2010 – Quintiles celebrates its 10th year anniversary in South Korea by announcing a strategic alliance with the Seoul National University Hospital (SNUH) as part of its unique Prime Site program.

QUINTILES, HKPI, RAMCO ANNOUNCE JOINT VENTURE IN EGYPT

Wed, 29 Sep 2010 08:58:07 -0400

September 29, 2010 - Quintiles, Health Kare Pharma International (HKPI), and Ramco Import and Export today announced the formation of a joint venture to provide commercialization services in Egypt.

HUYA, QUINTILES ANNOUNCE PARTNERSHIP TO CO-DEVELOP CANCER THERAPY

Tue, 28 Sep 2010 08:23:05 -0400

September 28, 2010 - HUYA Bioscience International (HUYA) and Quintiles announced an agreement to co-develop a new cancer drug, HBI-8000, sourced in China by HUYA.

QUINTILES AGAIN NAMED TO INFORMATIONWEEK 500

Wed, 15 Sep 2010 10:40:05 -0400

September 15, 2010 - Quintiles has again been named to the InformationWeek 500, the publication’s annual ranking of the nation’s most innovative users of business technology.

QUINTILES CENTRAL LABORATORY IN JAPAN RECEIVES CAP ACCREDITATION

Tue, 07 Sep 2010 06:00:00 -0400

September 7, 2010 - Quintiles' new lab in Tokyo, Japan has received accreditation from the College of American Pathologists (CAP), joining the largest network of fully harmonized, CAP-accredited central labs in the world.

PHARMAXIS SELECTS QUINTILES TO COMMERCIALIZE BRONCHITOL

Tue, 31 Aug 2010 09:00:00 -0400

August 31, 2010 – Quintiles announced a strategic agreement with Pharmaxis to provide a broad range of commercial solutions to support the European launch of Bronchitol®, an innovative treatment for cystic fibrosis.

NOBEL LAUREATE JOINS QUINTILES SCIENTIFIC ADVISORY BOARD

Wed, 11 Aug 2010 16:11:30 -0400

August 11, 2010 – Quintiles' announces the addition of Aaron Ciechanover, M.D., D.Sc., recipient of the Nobel Prize in Chemistry in 2004, to its Translational Research and Development Scientific Advisory Board.

QUINTILES EXTENDS DATA MANAGEMENT EXPERTISE, CAPABILITIES TO CHINA

Mon, 09 Aug 2010 06:00:00 -0400

August 9, 2010 - Quintiles announced the expansion of its data management services into Shanghai, China, strengthening the company’s capability to serve customers in that country and the Asia-Pacific region.

QUINTILES NAMES NEW CHIEF FINANCIAL OFFICER

Mon, 02 Aug 2010 14:07:59 -0400

August 2, 2010 – Quintiles announced the appointment of Kevin K. Gordon to serve as Chief Financial Officer (CFO). In this role, he will have day-to-day responsibility for the financial management of the company.

QUINTILES ANNOUNCES NEW EUROPEAN HEADQUARTERS

Thu, 29 Jul 2010 13:46:48 -0400

July 29, 2010 - Quintiles, announced that it is re-locating its European headquarters to within 30 minutes of Heathrow Airport at Green Park, Reading overlooking the M4 motorway.

QUINTILES NAMED ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION OF THE YEAR BY FROST & SULLIVAN

Fri, 09 Jul 2010 00:00:00 -0400

July 9, 2010 - Quintiles, has been named the 2010 Asia Pacific Contract Research Organization (CRO) Company of the Year by Frost & Sullivan.

QUINTILES ANNOUNCES CLINICAL RESEARCH PARTNERSHIP WITH THE UNIVERSITY MALAYA MEDICAL CENTRE

Mon, 05 Jul 2010 06:00:00 -0400

July 5, 2010 - Quintiles announces a strategic alliance agreement with the University Malaya Medical Centre (UMMC) as part of its unique Prime Site program.

THE NEW HEALTH REPORT REVEALS PERCEPTION GAPS AMONG BIOPHARMA STAKEHOLDERS

Tue, 15 Jun 2010 09:00:00 -0400

June 15, 2010 - Newly published report details the differences between bio pharma and other key stakeholders as they grapple with industry challenges.

THE NEW HEALTH REPORT FINDS GREATER INFLUENCE FOR PATIENTS ON DRUG DEVELOPMENT

Tue, 15 Jun 2010 09:00:00 -0400

June 15, 2010 - Patients are emerging as an increasingly strong group when it comes to influencing the success and failure of new drugs – according to a newly published New Health Report commissioned by Quintiles.

QUINTILES ANNOUNCES SUITE OF PI3K BIOMARKER ASSAYS TO ADVANCE ONCOLOGY THERAPIES TARGETING THIS CANCER PATHWAY

Mon, 07 Jun 2010 09:00:00 -0400

June 7, 2010 - Suite is part of Quintiles Global Central Labs’ ongoing efforts to advance personalized medicine.

QUINTILES RATED NO. 1 PREFERRED PROVIDER & INDUSTRY LEADER ACROSS ALL PHASES OF CLINICAL RESEARCH

Tue, 01 Jun 2010 09:14:14 -0400

June 1, 2010 – Quintiles most consistently meets or exceeds customer expectations and is the No. 1 preferred provider and perceived industry leader across all phases of clinical research.

QUINTILES BOLSTERS MARKET ACCESS CAPABILITIES IN UK

Thu, 20 May 2010 07:43:12 -0400

May 20, 2010 – Quintiles today announced an agreement under which Nycomed has transferred a U.K.-based Healthcare Solutions Team to further strengthen Quintiles’ market access capabilities.

QUINTILES AND KAISER PERMANENTE ANNOUNCE ALLIANCE TO ACCELERATE DRUG DEVELOPMENT

Tue, 18 May 2010 00:00:00 -0400

May 18, 2010 - Quintiles is accelerating drug development with the addition of Kaiser Permanente's Southern California Permanente Medical Group to its global site program

QUINTILES GLOBAL CENTRAL LAB IN CHINA EARNS PRESTIGIOUS NATIONAL AWARD FROM LEADING MEDICAL CENTER

Tue, 30 Mar 2010 11:24:05 -0400

March 30, 2010 – Quintiles’ Global Central Laboratory in China has won the national “Best Central Lab 2009” award from Shanghai Mental Health Center.

QUINTILES EXAMINES ASIA-PACIFIC DRUG DEVELOPMENT LANDSCAPE IN NEW REPORT

Wed, 17 Mar 2010 06:00:00 -0400

March 17, 2010 - A new report from Quintiles analyzes the Asia-Pacific pharmaceutical development landscape and its evolution from outsourcing destination to potential innovation hub.

QUINTILES ANNOUNCES NEW CENTRAL LAB IN JAPAN

Mon, 15 Mar 2010 18:00:00 -0400

March 15, 2010 – Quintiles announces that it has successfully relocated its Global Central Laboratory in Japan from Saitama to Tokyo to allow for expansion.

QUINTILES EXPANDS TO EAST AFRICA

Thu, 11 Mar 2010 09:39:24 -0400

March 11, 2010 - Quintiles has expanded its capacity in Africa with the opening of an office in Nairobi, Kenya.

QUINTILES EXTENDS PHASE I CAPACITY AND CAPABILITIES

Mon, 08 Mar 2010 18:24:54 -0400

March 8, 2010 – Quintiles announced the opening of its expanded research facility in London, UK, increasing its Phase I capacity and extending its ability to drive progress in translational medicine.

QUINTILES SPEEDS PATIENT RECRUITMENT WITH LOCAL MARKETING AUTOMATION TECHNOLOGY

Wed, 17 Feb 2010 11:12:46 -0400

February 17, 2010 - Named Quintiles Trial Enrollment Accelerator (QTEA), this new solution will speed patient recruitment by helping customers better manage the quality, consistency and effectiveness of messaging and media outreach.

QUINTILES ADDS TISSUE TESTING SERVICES IN CHINA

Tue, 16 Feb 2010 09:43:33 -0400

February 16, 2010 - Quintiles announced the availability of anatomic pathology services through its central laboratory in Beijing, China, to help biopharmaceutical companies develop more effective cancer treatments.

Quintiles Again Named to Training Top 125, for Workforce Training and Development Excellence

Mon, 08 Feb 2010 08:39:29 -0400

February 7, 2010 - Quintiles has again been named to Training magazine’s “Training Top 125,” the publication’s annual report that ranks companies based on their employer-sponsored training and development programs.

QUINTILES AND MOVETIS ANNOUNCE STRATEGIC ALLIANCE

Thu, 28 Jan 2010 10:32:01 -0400

January 28, 2010 - Quintiles announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany.

QUINTILES ANNOUNCES NEW POSITIONING, NEW BRAND IDENTITY

Mon, 25 Jan 2010 06:00:00 -0400

January 25, 2010 – Quintiles, the world’s leading biopharmaceutical services company, has launched a new positioning and brand identity, driven by the company’s growing ability to solve customers’ emerging clinical and commercial challenges.

QUINTILES EXECUTIVE ELECTED CHAIR-ELECT OF CDISC

Tue, 19 Jan 2010 09:30:17 -0400

January 19, 2010 – Quintiles announced that Paula Brown Stafford, Executive Vice President, Integrated Clinical Services, has been elected chair-elect of the Board of Directors of CDISC.

QUINTILES SELECTS INVIVODATA AS PRIMARY PARTNER FOR ePRO SOLUTIONS

Mon, 18 Jan 2010 09:53:33 -0400

January 18, 2010 — Quintiles and Invivodata, Inc. announced a collaboration agreement to transform the way Patient Reported Outcomes (PRO) are used in clinical research to speed drug development.

QUINTILES’ SUCCESS IN MANAGING STRATEGIC ALLIANCES PROFILED IN HARVARD BUSINESS REVIEW

Mon, 11 Jan 2010 06:00:00 -0400

January 11, 2010 - “Managing Alliances with the Balanced Scorecard” details how Solvay Pharmaceuticals and Quintiles managed their innovative development alliance to deliver value for both companies.

QUINTILES VIRTUAL CLINICAL RESEARCH COMMUNITY REACHES 2 MILLION

Tue, 22 Dec 2009 16:51:14 -0400

December 22, 2009 – Quintiles announced it has developed a community of more than 2 million clinically profiled patients who have opted in to volunteer or provide insights and guidance to advance clinical research through its proprietary Web site iGuard.org.

QUINTILES HONORED AS CRO OF THE YEAR AT 2009 SCRIP AWARD

Mon, 14 Dec 2009 12:02:36 -0400

December 14, 2009 – Quintiles has been named CRO of the Year by the prestigious SCRIP Awards. The panel of judges highlighted Quintiles’ breadth of services and its outstanding relationships with clients.

QUINTILES OPENS EXPANDED ASIA-PACIFIC HEADQUARTERS IN SINGAPORE

Fri, 06 Nov 2009 10:47:04 -0400

November 6, 2009 - To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles announced the official grand opening of its expanded Asia-Pacific regional headquarters facility in Singapore's Science Park I.

QUINTILES’ BILL DEAM NAMED TO CIO HALL OF FAME

Mon, 02 Nov 2009 15:42:10 -0400

November 2, 2009 - Quintiles Executive Vice President and Chief Information Officer (CIO) William “Bill” Deam has been named to the “CIO Hall of Fame” which selects honorees for their leadership in the CIO community and contributions to the advancement of the profession.

QUINTILES ANNOUNCES CLINICAL PHARMACOLOGY ALLIANCE WITH ASTRAZENECA

Mon, 02 Nov 2009 09:39:26 -0400

November 2, 2009 - Quintiles has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca’s clinical pharmacology studies across multiple therapy areas and around the globe.

QUINTILES ANNOUNCES STRATEGIC ALLIANCE TO ADVANCE EISAI’S ONCOLOGY PIPELINE

Fri, 30 Oct 2009 08:07:38 -0400

October 30, 2009 - Quintiles announced a strategic alliance with leading global pharmaceutical company Eisai Co. Ltd. (Tokyo, Japan) to develop six potential oncology products in Eisai’s R&D pipeline.

QUINTILES CONSULTING STRENGTHENS REGULATORY & QUALITY CAPABILITIES

Thu, 29 Oct 2009 08:51:24 -0400

October 29, 2009 - Quintiles Consulting announced three key appointments in its US Regulatory and Quality consulting practice expanding Quintiles’ experience in regulatory compliance and quality system development.

QUINTILES PARTNERS WITH FOUNDATION TRUST & UNIVERSITY TO IMPROVE PATIENT CARE AND DRIVE EFFICIENCY IN CLINICAL RESEARCH

Mon, 26 Oct 2009 11:53:57 -0400

October 26, 2009 - Guy’s and St Thomas’ NHS Foundation Trust and King’s College London sign collaborative agreement with Quintiles.

QUINTILES CONSULTING EXPLORES IMPACT OF COMPARATIVE EFFECTIVENESS RESEARCH ON DRUG DEVELOPMENT

Wed, 21 Oct 2009 13:45:26 -0400

October 21, 2009 – John Doyle, Vice President and Practice Leader for Quintiles Consulting, calls for a standard set of Comparative Effectiveness Research (CER) Principles.

QUINTILES AND CERNER WORK TOGETHER TO IMPROVE EFFICIENCY OF LATE PHASE RESEARCH STUDIES

Thu, 01 Oct 2009 16:21:56 -0400

October 1, 2009 – Global leaders in clinical research and electronic health record technology team up to streamline data collection and management.

QUINTILES LAUNCHES CLINICALRESEARCH.COM

Wed, 30 Sep 2009 11:19:49 -0400

September 30, 2009 - Patients who want to play an active role in bringing new, safer drugs to market faster now have access to a global Web site that makes it easier than ever before to identify clinical trials to participate in – regardless of geography or the drug company sponsor.

QUINTILES AND ALLERGAN ANNOUNCE CO-PROMOTION AGREEMENT

Fri, 25 Sep 2009 09:54:10 -0400

September 25, 2009 – Quintiles Transnational Corp. and Allergan, Inc. announced an agreement under which Quintiles will co-promote Allergan's SANCTURA XR®.

QUINTILES INCREASES CAPACITY TO SUPPORT EUROPEAN CLINICAL TRIALS

Thu, 24 Sep 2009 11:39:33 -0400

September 24, 2009 - Quintiles Transnational Corp. announced the opening of an expanded regional facility near Edinburgh, Scotland; space for Quintiles Clinical Development Services, including Project Management, Regulatory Affairs and Data Management.

QUINTILES DEBUTS AT #50 IN INFORMATIONWEEK 500

Tue, 15 Sep 2009 15:20:41 -0400

September 15, 2009 - Quintiles has been ranked in the 2009 InformationWeek 500, the publication’s annual ranking of the nation’s most innovative users of information technology. Quintiles was ranked 50th in its first time on the list.

QUINTILES ADDS DIGITAL PATHOLOGY SERVICES

Mon, 14 Sep 2009 10:45:23 -0400

September 14, 2009 - Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announced the availability of digital pathology services in Beijing, China. The services add to Quintiles offerings used in the development of therapies to treat the world’s most pressing health issues, including cancer.

QUINTILES ANNOUNCES CLINICAL RESEARCH PARNERSHIP WITH THE UNIVERSITY OF PRETORIA

Thu, 10 Sep 2009 13:54:23 -0400

September 10, 2009 – Quintiles Prime Site Program expands into South Africa to accelerate clinical development.

QUINTILES ANNOUNCES NEW GHANA OFFICE

Tue, 16 Jun 2009 13:30:31 -0400

June 16, 2009 - To improve efficiency and expand capacity to monitor the growing number of clinical studies being conducted in Western Sub-Saharan Africa, Quintiles announced the opening of a new office in Accra, Ghana.

QUINTILES AGAIN NAMED TO COMPUTERWORLD’s “100 BEST PLACES TO WORK IN IT” LIST

Mon, 15 Jun 2009 10:57:23 -0400

June 15, 2009 - Quintiles Transnational Corp. has been named to Computerworld magazine’s “100 Best Places to Work in IT” list for the second year in a row, improving to a ranking of 16th on the 2009 list.

QUINTILES CONSULTING OFFERS WHITE PAPER ON COST CONTAINMENT

Thu, 11 Jun 2009 10:49:05 -0400

June 11, 2009 - Quintiles Consulting released the first in a three-part series of white papers addressing how best to navigate risk in drug development.

QUINTILES WINS PFIZER DEVELOPMENT OPERATIONS STRATEGIC SUPPLIER EXCELLENCE AWARD

Wed, 10 Jun 2009 13:47:36 -0400

JUNE 10, 2009 – Quintiles announces that its Data Management division has received the 2008 Pfizer Development Operations’ Strategic Supplier Excellence Award.

QUINTILES ADVANCES CANCER TREATMENT THROUGH NEW GENETIC TESTS

Mon, 25 May 2009 11:43:19 -0400

May 26, 2009 – Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announces the availability of two new laboratory tests used to develop more effective cancer treatments.

QUINTILES ANNOUNCES APPOINTMENT OF NEW PRACTICE LEADER

Mon, 27 Apr 2009 13:37:57 -0400

April 28, 2009 - Quintiles Consulting announced the appointment of James Kirk as Practice Leader for Eidetics, the Market Intelligence and Analytics Practice of Quintiles Consulting.

QUINTILES NAMED BEST CLINICAL SERVICE PROVIDER

Thu, 23 Apr 2009 11:12:39 -0400

April 23, 2009 - Quintiles was named by industry decision-makers as the most favored contract research organization (CRO), according to two recently released independent surveys.

QUINTILES CANADA RECOGNIZED AS A GREAT PLACE TO WORK

Wed, 15 Apr 2009 15:25:10 -0400

April 15, 2009 - Quintiles has been recognized by the Great Place to Work® (GPTW) Institute Canada as one of the top 25 companies to work for in the country.

QUINTILES REACHES 400TH TRIAL USING ELECTRONIC DATA CAPTURE

Thu, 02 Apr 2009 14:57:40 -0400

April 2, 2009 – Quintiles Transnational Corp. announced the achievement of another industry-leading milestone – its 400th clinical trial using Electronic Data Capture (EDC).

QUINTILES GLOBAL CENTRAL LABORATORY NETWORK SETS NEW STANDARD

Wed, 11 Mar 2009 14:13:15 -0400

March 11, 2009 – Quintiles Transnational Corp. has the largest CAP-accredited central laboratory network in the world - setting a standard for patient safety and faster drug development.

QUINTILES CENTRAL LAB IN ARGENTINA RECEIVES CAP ACCREDITATION

Wed, 11 Mar 2009 09:14:44 -0400

March 11, 2009 - Quintiles Central Lab in Buenos Aires is latest facility to be accredited in the world’s largest CAP-accredited lab network.

QUINTILES NAMED TO TRAINING TOP 125 FOR WORKFORCE TRAINING AND DEVELOPMENT EXCELLENCE

Thu, 26 Feb 2009 13:37:15 -0400

February 26, 2009 – Quintiles Transnational Corp. has been named to TRAINING magazine’s “Training Top 125,” the publication’s annual report that ranks companies based on their employer-sponsored training and development programs.

QUINTILES TO OPEN PHASE I UNIT IN INDIA

Tue, 27 Jan 2009 11:14:10 -0400

January 27, 2009 – Quintiles Transnational Corp. announced a partnership with Apollo Hospitals Group to open a Phase I clinical trial unit in Hyderabad, India.

QUINTILES MOVES TO SPEED DEVELOPMENT OF CANCER THERAPIES

Thu, 15 Jan 2009 12:26:24 -0400

January 15, 2009 - Quintiles Transnational Corp. announced that it has adopted “common contract language” to significantly reduce contract negotiation time, and shorten the drug testing process.

QUINTILES ACQUIRES TARGETED MOLECULAR DIAGNOSTICS (TMD)

Mon, 01 Dec 2008 10:15:31 -0400

December 1, 2008 - Quintiles Transnational Corp. today announced that it has acquired Targeted Molecular Diagnostics (TMD) of Westmont, Ill.

QUINTILES, SAS ANNOUNCE DEVELOPMENT OF FIRST-EVER CLINICAL TRIALS STATISTICAL PROGRAMMING CERTIFICATION

Wed, 19 Nov 2008 14:36:21 -0400

November 19, 2008 - Quintiles, the world’s No. 1 pharmaceutical services company, and SAS are developing a unique program to produce certified specialists in the use of SAS programming to evaluate clinical trials results, the companies announced today.

EIDETICS LAUNCHES GROUNDBREAKING DATA VISUALIZATION

Fri, 24 Oct 2008 17:07:43 -0400

October 24, 2008 - Eidetics, a leading global healthcare market research firm and division of Quintiles Consulting, announced the commercial launch of their proprietary service application, Provenance.

QUINTILES RECOGNIZED AMONG "BEST COMPANIES TO WORK FOR" IN BRAZIL

Thu, 11 Sep 2008 17:41:27 -0400

September 11, 2008 -- Quintiles has been recognized by the Great Places to Work® (GPTW) Institute as one of the top 100 “Best Companies to Work For” in Brazil.

QUINTILES NAMED TO COMPUTERWORLD MAGAZINE’S ‘100 BEST PLACES TO WORK IN IT’

Mon, 14 Jul 2008 15:16:08 -0400

July 14, 2008 – Quintiles Transnational Corp. has been named to Computerworld magazine’s 2008 list of the "100 Best Places to Work in IT."

QUINTILES SIGNS AGREEMENT TO ACQUIRE EIDETICS

Wed, 07 May 2008 15:39:52 -0400

May 7, 2008 - Quintiles Transnational Corp. announced that it has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business.

QUINTILES CONSULTING BUSINESS EXPANDS; NEW PRACTICE LEADERS APPOINTED

Tue, 22 Apr 2008 15:56:13 -0400

April 22, 2008 – Quintiles Transnational Corp. announced the appointment of three new practice leaders and a business development head as part of its expanding Quintiles Consulting business.

QUINTILES APPOINTS OREN COHEN TO SENIOR VICE PRESIDENT, CLINICAL RESEARCH STRATEGIES

Wed, 16 Apr 2008 16:14:39 -0400

April 16, 2008 – Quintiles Transnational Corp. announced the appointment of Oren Cohen, M.D. as Senior Vice President, Clinical Research Strategies.

QUINTILES TO PROVIDE CENTRAL LAB SERVICES IN JAPAN

Wed, 26 Mar 2008 17:45:39 -0400

March 26, 2008 – Quintiles Transnational Corp. announced an agreement with Medca Japan to provide central laboratory services, further extending the Quintiles global network of laboratories certified by the College of American Pathologists (CAP).

QUINTILES DATA MANAGEMENT SURPASSES 300 EDC TRIALS

Wed, 05 Mar 2008 17:49:47 -0400

March 5, 2008 – Quintiles Transnational Corp. announced it has achieved another major milestone in the management of clinical trial data – 300 clinical trials using Electronic Data Capture (EDC).

QUINTILES CENTRAL LABORATORY IN INDIA RECEIVES CAP CERTIFICATION

Wed, 13 Feb 2008 16:34:40 -0400

February 13, 2008 – Quintiles Transnational Corp. announced that its central laboratory in India has been certified by the College of American Pathologists (CAP).

QUINTILES COMPLETES PREVIOUSLY ANNOUNCED NEW INVESTOR PARTNERSHIP

Thu, 24 Jan 2008 17:23:31 -0400

January 24, 2008 – Quintiles Transnational Corp. announced the completion of its previously announced new investor partnership to support the company’s continued growth under the leadership of founder and current Chairman and CEO Dennis Gillings, CBE, and the management team.

QUINTILES TO OPEN CLINICAL RESEARCH OFFICE IN WILMINGTON, NC

Thu, 17 Jan 2008 17:53:22 -0400

January 17, 2008 – Quintiles Transnational Corp. announced that the global leader in pharmaceutical services will open an office in Wilmington, N.C.

QUINTILES CENTRAL LAB, CLINICAL DEVELOPMENT IN CHINA TO EXPAND, RELOCATE TO NEW FACILITY

Wed, 09 Jan 2008 17:57:04 -0400

January 9, 2008 – Quintiles Transnational Corp. announced the expansion and consolidation of its Global Central Laboratories and Clinical Development Services (CDS) units in Beijing to accommodate their growing business in China.

QUINTILES NAMES KELLY MCKEE EXECUTIVE DIRECTOR OF OPERATIONS FOR PUBLIC HEALTH AND GOVERNMENT SERVICES UNIT

Wed, 09 Jan 2008 17:29:05 -0400

January 9, 2008 – Quintiles Transnational Corp. announced the appointment of Kelly McKee, M.D., as Executive Director of Operations for the company’s Public Health and Government Services unit.

QUINTILES NAMES HEAD OF STRATEGIC RESEARCH, MEDICAL, REGULATORY, AND SAFETY SERVICES

Tue, 08 Jan 2008 17:34:04 -0400

January 8, 2008 – Quintiles Transnational Corp. announced the appointment of Dipti Amin, M.D., as Senior Vice President of Strategic Research and Safety Services (SRS) and Medical and Regulatory Services, effective immediately.

QUINTILES TRANSNATIONAL FORMS NEW OWNERSHIP TEAM WITH CURRENT INVESTORS GILLINGS, TPG AND TEMASEK JOINED BY BAIN CAPITAL

Fri, 21 Dec 2007 15:52:38 -0400

December 21, 2007 – Quintiles Transnational Corp. today announced the formation of a new investor partnership to support the company’s continued growth under the leadership of current Chairman and CEO Dennis Gillings, CBE, and the management team.

QUINTILES APPOINTS JOHN GOODACRE AS GENERAL COUNSEL

Tue, 11 Dec 2007 16:19:27 -0400

December 11, 2007 – Quintiles Transnational Corp. today announced the appointment of John Goodacre as Executive Vice President and General Counsel.

QUINTILES CONSULTING ENTERS RESEARCH PARTNERSHIP

Wed, 07 Nov 2007 10:11:26 -0400

November 7, 2007 – Quintiles Consulting announced a new research partnership with the Institute for Life Sciences Business Economics (iLSBE) at the Erasmus University of Rotterdam.

QUINTILES ACQUIRES CENTRAL AMERICAN RESEARCH ORGANIZATION

Tue, 30 Oct 2007 13:21:27 -0400

October 30, 2007 – Quintiles Transnational Corp. today announced that its Latin American subsidiary has purchased Bio-Trials, a leading Central American Clinical Research Organization (CRO) with headquarters in Panama and offices in Costa Rica, Guatemala, Ecuador and Peru.

EXPERT CARDIOLOGIST JOINS QUINTILES MEDICAL GROUP

Fri, 26 Oct 2007 13:48:09 -0400

October 26, 2007 – Quintiles Transnational Corp. today announced that Christopher H. Cabell, M.D., MHS, FACC, an expert cardiologist and clinical investigator, has joined the Medical & Scientific Services group in Global Clinical Development Services (CDS). In addition to his CDS work, he provides U.S.-based cardiology expertise for Quintiles ECG Services.

QUINTILES APPOINTS JAY D. NORMAN TO EXPAND CONSULTING BUSINESS

Mon, 08 Oct 2007 14:10:17 -0400

October 8, 2007 – Quintiles Transnational Corp. today announced the appointment of Jay D. Norman to serve as President of its expanding Quintiles Consulting business, which helps pharmaceutical, biotech and medical device companies maximize potential and minimize risk from early discovery through commercialization.

MICHAEL TROULLIS APPOINTED CHIEF FINANCIAL OFFICER OF QUINTILES TRANSNATIONAL CORP.

Wed, 15 Aug 2007 14:32:41 -0400

August 15, 2007 – Quintiles Transnational Corp. today announced the appointment of Michael Troullis as its Chief Financial Officer, effective immediately. Troullis had been acting CFO since former CFO John Ratliff was appointed Quintiles’ Chief Operating Officer last year.

QUINTILES TO ADD JOBS, CONSOLIDATE ATLANTA FACILITIES

Thu, 05 Jul 2007 08:33:28 -0400

July 5, 2007 – Quintiles Transnational Corp. today announced plans to expand and consolidate its Global Central Laboratories in Smyrna, Ga., and its Clinical Development Services (CDS) office in Atlanta within a single structure in nearby Marietta, Ga.

QUINTILES ASIA PACIFIC WINS THREE AWARDS FOR EXCELLENCE

Mon, 11 Jun 2007 14:56:40 -0400

RESEARCH TRIANGLE PARK, N.C. – June 11, 2007 – Quintiles Transnational Corp. today announced that its Asia Pacific unit has received three awards for excellence in customer service.

QUINTILES CLINICAL TRIAL MONITORS RATED BEST IN INDUSTRY

Mon, 11 Jun 2007 14:51:26 -0400

June 11, 2007 – Quintiles Transnational Corp. today announced that clinical investigators rate Quintiles’ clinical trial monitors as the best in the industry, according to a recent survey.

QUINTILES AND THERMO FISHER SCIENTIFIC CREATE JOINT VENTURE TO PROVIDE INTEGRATED RESPONSE TECHNOLOGY SERVICES

Mon, 21 May 2007 15:11:04 -0400

May 21, 2007 – Quintiles Transnational Corp. and Thermo Fisher Scientific Inc. (NYSE: TMO) today announced the creation of a joint venture, called Cenduit™, that provides seamless, integrated Interactive Response Technology (IRT) services for pharmaceutical and biotechnology product development.

QUINTILES FOUNDER DEDICATES NEW FACILITY FOR CLINICAL RESEARCH IN OVERLAND PARK, KANSAS

Tue, 15 May 2007 15:15:56 -0400

May 15, 2007 – Dennis Gillings, CBE, Chairman and CEO of Quintiles Transnational Corp., today dedicated a new Quintiles facility in Overland Park, Kan., with Secretary David Kerr of the Kansas Department of Commerce and other dignitaries attending.

NEW REGULATORY TEAM AT QUINTILES HELPS BRING BIOTECHNOLOGY PRODUCTS TO MARKET

Mon, 07 May 2007 15:25:51 -0400

May 7, 2007 – Quintiles Transnational Corp. today announced the formation of a global biologics regulatory team to advise customers about development plans and optimal strategy for regulatory submissions for vaccines, monoclonal antibodies, stem-cell based therapies and other biological products.

QUINTILES CELEBRATES 10 YEARS IN INDIA WITH DEDICATION OF NEW LAB

Fri, 06 Apr 2007 08:57:19 -0400

April 6, 2007 – Dennis Gillings, CBE, Chairman and CEO of Quintiles Transnational Corp., today dedicated the company’s new central lab in Mumbai, India, and congratulated Quintiles India for its 10 years of growth and leadership in clinical research.

COMMERCE SECRETARY FAIN JOINS QUINTILES IN DEDICATING NEW DATA PROCESSING CENTER IN EASTERN NORTH CAROLINA

Tue, 13 Feb 2007 09:02:40 -0400

Feb. 13, 2007 – Dennis Gillings, CBE, Chairman and CEO of Quintiles Transnational Corp., was joined yesterday in the formal opening of Quintiles’ new data processing facility in Williamston, N.C., by North Carolina Commerce Department Secretary Jim Fain, together with N.C. Rep. Edith Warren; Tommy Bowen, Chairman of the Martin County Board of Commissioners; Stan Crowe, Chairman of the Martin County Economic Development Commission; and Jane Patterson, Executive Director of the e-NC Authority, a division of the North Carolina Rural Economic Development Center.

QUINTILES DATA MANAGEMENT HEAD ELECTED TO CDISC BOARD

Mon, 06 Nov 2006 09:12:52 -0400

November 6, 2006 – Quintiles Transnational Corp. today announced that Paula Brown Stafford, Executive Vice President, Global Data Management, has been elected to the Board of Directors of CDISC, an industry consortium that leads the development of data standards to improve medical research.

SOLVAY, QUINTILES ANNOUNCE FIVE-YEAR RENEWAL OF DRUG DEVELOPMENT STRATEGIC ALLIANCE

Tue, 24 Oct 2006 09:21:13 -0400

October 24, 2006 – Solvay Pharmaceuticals has renewed for another five years its clinical development strategic alliance with Quintiles, first signed in 2001, Solvay Pharmaceuticals and Quintiles Transnational Corp. announced today. The renewal reflects the alliance's success in accelerating development of Solvay's product portfolio and improving efficiency.

QUINTILES TO OPEN CENTRAL LABORATORY IN MUMBAI, INDIA

Mon, 16 Oct 2006 09:38:45 -0400

October 16, 2006 – Quintiles Transnational Corp. today announced plans to open a central lab in Mumbai, India, further expanding the company’s global network of labs that support global and regional clinical trials.

JOHN RATLIFF APPOINTED CHIEF OPERATING OFFICER OF QUINTILES TRANSNATIONAL CORP.

Mon, 02 Oct 2006 09:42:48 -0400

October 2, 2006 – Quintiles Transnational Corp. today announced that John Ratliff has been appointed as its new Chief Operating Officer, effective immediately. He will be responsible for directing Quintiles’ daily global operations and will report to Chairman and Chief Executive Officer, Dennis Gillings, CBE. Ratliff also has been elected to the Quintiles Transnational Corp. Board of Directors.

QUINTILES TO OPEN DATA PROCESSING CENTER IN MARTIN COUNTY, N.C.

Tue, 08 Aug 2006 09:50:04 -0400

August 8, 2006 – Quintiles Transnational Corp. today announced the expansion of its global data management network with the opening of a clinical data processing center in Williamston, N.C. The center will provide up to 70 new jobs in the eastern region of the state and build additional capacity for customers seeking services provided by U.S.-based staff.

HIGH-RANKING FDA OFFICIAL STEVEN NIEDELMAN JOINS QUINTILES CONSULTING AS EXECUTIVE VICE PRESIDENT

Tue, 01 Aug 2006 09:54:10 -0400

August 1, 2006 – Steven M. Niedelman, formerly deputy associate commissioner for Regulatory Operations for the U.S. Food and Drug Administration, has joined Quintiles Consulting as executive vice president, Quintiles Transnational Corp. announced today.

QUINTILES CREATES BIOSTATISTICS UNIT TO REDUCE TIME AND COSTS OF DRUG DEVELOPMENT

Mon, 24 Jul 2006 09:58:16 -0400

July 24, 2006 – Quintiles Transnational Corp. today announced the creation of the Strategic Biostatistics Unit to help customers cut the time and reduce the costs of drug development through the "adaptive design" of clinical trials and other innovative statistical approaches.

QUINTILES ASIA PACIFIC RECEIVES FROST & SULLIVAN AWARDS

Tue, 06 Jun 2006 10:01:29 -0400

June 6, 2006 – Quintiles Transnational Corp. today announced that its Quintiles East Asia subsidiary has been named the Asia Pacific region's Multinational Clinical Trials Service Provider of the Year and Multinational CRO of the Year by the consulting firm Frost & Sullivan.

QUINTILES COMPLETES REFINANCING AND ACCEPTS NOTES IN TENDER OFFER

Fri, 31 Mar 2006 10:11:50 -0400

March 31, 2006 – Quintiles Transnational Corp. today announced that it has completed new credit facility arrangements. The new credit facilities include a $225 million first lien revolving credit facility due in 2012, a $1.0 billion first lien term loan due in 2013 and a $220 million second lien term loan due in 2014. Proceeds from the borrowings under the term loans were used, together with available cash, to pay the purchase price for notes accepted in the tender offer described below and to cash out the outstanding preferred stock of Pharma Services Holding, Inc. ("Pharma Services"), the parent company of Quintiles, as part of the mergers of Pharma Services and Pharma Services Intermediate Holding Corp. ("Holding") into Quintiles.

YOH NARIMATSU APPOINTED PRESIDENT AND CHIEF EXECUTIVE OFFICER OF QUINTILES JAPAN

Wed, 29 Mar 2006 10:14:51 -0400

March 29, 2006 – Quintiles Transnational Corp. today announced the appointment of Yoh Narimatsu as President and Chief Executive Officer of Quintiles Transnational Japan K.K. (Quintiles Japan) effective April 1.

QUINTILES TRANSNATIONAL CORP. ANNOUNCES DONATION TO SEATTLE VACCINE RESEARCH FUND

Tue, 21 Mar 2006 10:21:01 -0400

March 21, 2006 – Quintiles Transnational Corp., the world's leading pharmaceutical services organization, today announced it has donated $100,000 to the Seattle Vaccine Research Fund (SVRF) to support anti- retroviral treatment for HIV vaccine trial participants who become infected during vaccine studies.

QUINTILES DATA MANAGEMENT TO CONDUCT 200TH EDC TRIAL

Mon, 20 Mar 2006 10:43:33 -0400

March 20, 2006 – Quintiles Transnational Corp. today announced that it has reached a significant milestone in data management – the 200th clinical trial using Electronic Data Capture (EDC).

QUINTILES ANNOUNCES RECEIPT OF REQUISITE CONSENTS DUE 2013 AND 11.5% SENIOR DISCOUNT NOTES DUE 2014

Fri, 17 Mar 2006 10:27:32 -0400

March 17, 2006 – Quintiles Transnational Corp. ("Quintiles") and Pharma Services Intermediate Holding Corp. ("Holding;" each of Holding and Quintiles, is referred to as a "Company") today announced that, in connection with the previously announced tender offer and consent solicitation for any and all of Quintiles' outstanding $450.0 million aggregate principal amount 10% senior subordinated notes due 2013 (CUSIP Nos. 748767 AE0 and 748767 AD2)(the "Subordinated Notes") and any and all of Holding's outstanding $219.0 million aggregate principal amount at maturity 11.5% senior discount notes due 2014 (CUSIP No. 71711W AB6)(the "Discount Notes"), the requisite consents have been received to approve certain amendments to the indentures under which the respective Notes were issued. The amendments to the indentures will eliminate or make less restrictive most of the restrictive covenants contained in the indentures and amend certain related provisions.

QUINTILES COMMENCES REFINANCING PROCESS

Mon, 06 Mar 2006 10:31:27 -0400

March 6, 2006 – Quintiles Transnational Corp. today announced that it is pursuing plans to borrow $1.47 billion under new credit facility arrangements. The new credit facilities would include a $250 million first lien revolving credit facility due in 2012, a $900 million first lien term loan B due in 2013 and a $320 million second lien term loan C due in 2014. Proceeds from these borrowings would be used, together with available cash, to pay the purchase price for notes tendered in the tender offer announced by the Company and Pharma Services Intermediate Holding Corp. ("Holding") on March 3, 2006, with respect to any and all of their outstanding senior notes, and to cash out the outstanding preferred stock of Pharma Services Holding, Inc., the parent company of the Company and Holding. The refinancing and the tender offer are subject to certain conditions, rights of withdrawal and other terms which could result in the Company not completing the refinancing or tender offer.

QUINTILES COMMENCES TENDER OFFER

Fri, 03 Mar 2006 10:38:57 -0400

March 3, 2006 – Quintiles Transnational Corp. today announced that it and Pharma Services Intermediate Holding Corp. ("Holding;" each of Holding and Quintiles, is referred to as a "Company") have commenced a cash tender offer for any and all of Quintiles' outstanding $450.0 million aggregate principal amount 10% senior subordinated notes due 2013 (CUSIP Nos. 748767 AE0 and 748767 AD2) (the "Subordinated Notes") and any and all of Holding's outstanding $219.0 million aggregate principal amount at maturity 11.5% senior discount notes due 2014 (CUSIP No. 71711W AB6) (the "Discount Notes"). The Subordinated Notes and the Discount Notes are collectively referred to as the "Notes." In connection with the cash tender offer, each Company is also soliciting consents to amend the indentures under which the respective Notes were issued to eliminate or make less restrictive most of the restrictive covenants contained in the indentures and amend certain related provisions.

QUINTILES TO BUILD NEW HOME FOR ALL KANSAS CITY AREA OPERATIONS

Fri, 10 Feb 2006 10:48:37 -0400

February 10, 2006 – Quintiles Transnational Corp. today announced it will build a new structure in Overland Park, Kan., to house the Clinical Development Services (CDS) and Clinical Pharmacology units now in Kansas City and the Phase I Clinical Research unit located in Lenexa, Kan.

QUINTILES LABORATORY IN BEIJING RECEIVES TWO KEY CERTIFICATIONS

Fri, 20 Jan 2006 11:00:46 -0400

January 20, 2006 – Quintiles Transnational Corp. today announced that its central laboratory operation in China has earned two significant certifications – one from the College of American Pathologists (CAP) and the other from the National Glycohemoglobin Standardization Program (NGSP).

QUINTILES REPORTS 3rd QUARTER NET REVENUE OF $470.3 MILLION, UP 19%

Mon, 14 Nov 2005 11:16:20 -0400

November 14, 2005 – Quintiles Transnational Corp. today announced financial results for the quarter ended September 30, 2005. Net revenue for third quarter 2005 was $470.3 million, an increase of 19% from net revenue of $396.5 million for third quarter 2004. Profit contribution from Quintiles' Product Development and Commercial Services groups totaled $210.5 million in third quarter 2005, up from $193.1 million for third quarter 2004.

QUINTILES TRANSNATIONAL ANNOUNCES LIVE WEBCAST FOR THIRD QUARTER EARNINGS

Thu, 10 Nov 2005 11:23:04 -0400

November 10, 2005 – Quintiles Transnational Corp. today announced that it will conduct a live webcast of its third quarter 2005 earnings release conference call on Tuesday, Nov. 15, at 11:00 a.m. EST.

QUINTILES COMPLETES AGREEMENT WITH APTUIT

Fri, 30 Sep 2005 11:28:23 -0400

Sept. 30, 2005 – Quintiles Transnational Corp. today announced the completion of the previously announced agreement with Aptuit, Inc., to enter a strategic partnership.

QUINTILES SUBSIDIARY TO PRIVATELY OFFER DULOXETINE SECURED NOTES

Fri, 19 Aug 2005 11:31:45 -0400

August 19, 2005 – Quintiles Transnational Corp. today announced that its newly formed subsidiary, Duloxetine Royalty Sub (“Royalty Sub”), intends to issue $150 million of Duloxetine Secured Notes, plus as much as $50 million to $150 million of additional notes, depending on market and other conditions. Quintiles expects to use the net proceeds it will receive from Royalty Sub to repay in full all outstanding term loans, if any, under Quintiles’ existing senior secured credit facility, for any other purposes permitted under Quintiles’ other debt arrangements and for general corporate purposes.

QUINTILES REPORTS 2nd QUARTER NET REVENUE OF $537 MILLION, UP 26 PERCENT

Fri, 12 Aug 2005 11:35:28 -0400

August 12, 2005 – Quintiles Transnational Corp. today announced financial results for the quarter ended June 30, 2005. Net revenue for second quarter 2005 was $537.4 million, an increase of 26% from net revenue of $425.8 million for second quarter 2004. Contribution from Quintiles' Product Development and Commercial Services groups totaled $243.0 million in second quarter 2005, up 28% from $189.7 million for second quarter 2004.

QUINTILES TRANSNATIONAL ANNOUNCES LIVE WEBCAST FOR SECOND QUARTER EARNINGS

Tue, 09 Aug 2005 11:40:18 -0400

August 9, 2005 – Quintiles Transnational Corp. today announced that it will conduct a live webcast of its second quarter 2005 earnings release conference call on Friday, Aug. 12, at 1:00 p.m. EDT.

FDA LEADER JOINS QUINTILES' REGULATORY GROUP

Tue, 02 Aug 2005 12:58:15 -0400

August 2, 2005 – Quintiles Transnational Corp. today announced the appointment of an expert in the regulation of pharmaceutical and biotechnology products, Edward Tabor, M.D., as Executive Director, Regulatory & Technical Services.

KIYOTAKA FUJII APPOINTED PRESIDENT AND CHIEF EXECUTIVE OFFICER OF QUINTILES JAPAN

Thu, 21 Jul 2005 11:47:02 -0400

July 21, 2005 – Quintiles Transnational Corp. today announced the appointment of Kiyotaka Fujii as President and Chief Executive Officer of Quintiles Transnational Japan K.K. (Quintiles Japan) as of August 1, 2005.

INTERPHARMA, QUINTILES AND TEMASEK TO FORM JOINT VENTURE

Thu, 09 Jun 2005 11:57:42 -0400

June 9, 2005 – Three global companies have announced a joint venture to commercialize pharmaceutical products in the Asia Pacific region. Partners in the joint venture, which will have an investment fund totaling US$112 million, include leading Asia Pacific pharmaceutical services group, Interpharma Asia Pacific, parent of drug distributor Zuellig Pharma; Asia investment company Temasek Holdings (Private) Limited; and Quintiles Transnational Corp., the world's leading pharmaceutical services organization, who has signed a letter of intent to join the venture. Each partner is expected to make an equal investment in the joint venture and own one-third each of the company.

QUINTILES LABORATORIES ASIA ENHANCES SERVICES IN CHINA

Thu, 02 Jun 2005 12:10:14 -0400

June 2, 2005 – Quintiles Transnational Corp. today announced that Quintiles Laboratories Asia (QLAB Asia) has amended its existing agreement with Peking Union Medical College Hospital (PUMCH) to enhance central laboratory services in China.

QUINTILES, MIAMI CHILDRENS HOSPITAL CREATE ALLIANCE FOR PEDIATRIC STUDIES

Tue, 31 May 2005 13:02:46 -0400

May 31, 2005 – Quintiles Inc., the North American clinical development subsidiary of Quintiles Transnational Corp., and Miami Children's Hospital in Florida today announced an alliance for clinical research.

QUINTILES REPORTS 1st QUARTER NET REVENUE OF $492 MILLION, UP 16 PERCENT

Fri, 13 May 2005 12:14:54 -0400

May 13, 2005 – Quintiles Transnational Corp. today announced financial results for the quarter ended March 31, 2005. Net revenue for first quarter 2005 was $492.4 million, an increase of 16% from net revenue of $423.2 million for the same quarter in 2004. Contribution for Quintiles' Product Development and Commercial Services groups totaled $217.2 million in first quarter 2005 versus $182.6 million for the same quarter in 2004. Net income for first quarter 2005 was $19.3 million, compared with a loss of $15.7 million for first quarter 2004.

QUINTILES DESIGNATED STRATEGIC PARTNER BY ROCHE

Thu, 12 May 2005 13:08:31 -0400

May 12, 2005 – Quintiles Transnational Corp. announced it has entered a partnership with Roche for clinical study management services.

QUINTILES TRANSNATIONAL ANNOUNCES LIVE WEBCAST FOR FIRST QUARTER EARNINGS

Wed, 11 May 2005 12:21:18 -0400

May 11, 2005 – Quintiles Transnational Corp. today announced that it will conduct a live webcast of its first quarter 2005 earnings release conference call on Monday, May 16, at 11:00 a.m. EDT.

QUINTILES REPORTS 2004 NET REVENUE OF $1.78 BILLION

Mon, 07 Mar 2005 12:27:17 -0400

March 7, 2005 – Quintiles Transnational Corp. today announced financial results for the year and quarter ended Dec. 31, 2004. Net revenue for 2004 was $1.78 billion versus $1.63 billion in 2003. Contribution for Quintiles' Product Development and Commercial Services groups totaled $808.1 million for 2004 versus $713.7 million for 2003. Net income for 2004 was $1.0 million, compared with $29.7 million for 2003.